Skip to main content
Top
Published in: Breast Cancer Research 3/2013

01-06-2013 | Review

Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors

Author: David N Danforth Jr Jr

Published in: Breast Cancer Research | Issue 3/2013

Login to get access

Abstract

Breast cancer is the most common malignancy in women in the United States but significant disparities exist for African American women compared to Caucasian women. African American women present with breast cancer at a younger age and with a greater incidence under the age of 50 years, develop histologically more aggressive tumors that are at a more advanced stage at presentation, and have a worse disease-free and overall survival than Caucasian women. The biological characteristics of the primary tumor play an important role in determining the outcome of the disparity, and significant differences have been identified between African American and Caucasian breast cancer in steroid receptor and growth factor receptor content, mutations in cell cycle components, chromosomal abnormalities, and tumor suppressor and other cancer genes. The consequences of the biological factors are influenced by a variety of nonbiological factors, including socioeconomic, health care access, reproductive, and confounding factors. The nonbiological factors may act directly to enhance (or inhibit) the consequences of the biological changes, indirectly to facilitate outcome of the disparity, or as a cofounding factor, driving the association between the biological factors and the disparity. The prevention and management of the disparities will require an understanding of the relationship of biological and nonbiological factors. The present review was undertaken to promote this understanding by describing the biological basis of the four major disparities - early age of onset, more advanced stage of disease, more aggressive histologic changes, and worse survival - and the important relationship to the nonbiological factors. A model is proposed to provide a comprehensive view of this relationship, with the goal of facilitating an understanding of each disparity and the issues that need to be addressed to eliminate the disparity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 2012, 62: 10-29. 10.3322/caac.20138.CrossRefPubMed Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 2012, 62: 10-29. 10.3322/caac.20138.CrossRefPubMed
3.
go back to reference Pinheiro SP, Holmes MD, Pollak MN, Barbieri RL, Hankinson SE: Racial differences in premenopausal endogenous hormones. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2147-2153. 10.1158/1055-9965.EPI-04-0944.CrossRefPubMed Pinheiro SP, Holmes MD, Pollak MN, Barbieri RL, Hankinson SE: Racial differences in premenopausal endogenous hormones. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2147-2153. 10.1158/1055-9965.EPI-04-0944.CrossRefPubMed
4.
go back to reference Hall IJ, Moorman PG, Millikan RC, Newman B: Comparative analysis of breast cancer risk factors among African-American women and White women. Am J Epidemiol. 2005, 161: 40-51. 10.1093/aje/kwh331.CrossRefPubMed Hall IJ, Moorman PG, Millikan RC, Newman B: Comparative analysis of breast cancer risk factors among African-American women and White women. Am J Epidemiol. 2005, 161: 40-51. 10.1093/aje/kwh331.CrossRefPubMed
5.
go back to reference Chen VW, Correa P, Kurman RJ, Wu XC, Eley JW, Austin D, Muss H, Hunter CP, Redmond C, Sobhan M: Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev. 1994, 3: 127-135.PubMed Chen VW, Correa P, Kurman RJ, Wu XC, Eley JW, Austin D, Muss H, Hunter CP, Redmond C, Sobhan M: Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev. 1994, 3: 127-135.PubMed
6.
go back to reference Weiss SE, Tartter PI, Ahmed S, Brower ST, Brusco C, Bossolt K, Amberson JB, Bratton J: Ethnic differences in risk and prognostic factors for breast cancer. Cancer. 1995, 76: 268-274. 10.1002/1097-0142(19950715)76:2<268::AID-CNCR2820760217>3.0.CO;2-1.CrossRefPubMed Weiss SE, Tartter PI, Ahmed S, Brower ST, Brusco C, Bossolt K, Amberson JB, Bratton J: Ethnic differences in risk and prognostic factors for breast cancer. Cancer. 1995, 76: 268-274. 10.1002/1097-0142(19950715)76:2<268::AID-CNCR2820760217>3.0.CO;2-1.CrossRefPubMed
7.
go back to reference Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA, Adams-Campbell LL, Prentice R: Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005, 97: 439-448. 10.1093/jnci/dji064.CrossRefPubMed Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA, Adams-Campbell LL, Prentice R: Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005, 97: 439-448. 10.1093/jnci/dji064.CrossRefPubMed
8.
go back to reference Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC, Wang X, Ademuyiwa F, Ahmed S, Ambrosone CB, Baglietto L, Balleine R, Bandera EV, Beckmann MW, Berg CD, Bernstein L, Blomqvist C, Blot WJ, Brauch H, Buring JE, Carey LA, Carpenter JE, Chang-Claude J, Chanock SJ, Chasman DI, Clarke CL, Cox A, Cross SS, Deming SL, Diasio RB, et al: A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet. 2011, 43: 1210-1214. 10.1038/ng.985.CrossRefPubMedPubMedCentral Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC, Wang X, Ademuyiwa F, Ahmed S, Ambrosone CB, Baglietto L, Balleine R, Bandera EV, Beckmann MW, Berg CD, Bernstein L, Blomqvist C, Blot WJ, Brauch H, Buring JE, Carey LA, Carpenter JE, Chang-Claude J, Chanock SJ, Chasman DI, Clarke CL, Cox A, Cross SS, Deming SL, Diasio RB, et al: A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet. 2011, 43: 1210-1214. 10.1038/ng.985.CrossRefPubMedPubMedCentral
9.
go back to reference Kato I, Cichon M, Yee CL, Land S, Korczak JF: African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer. Cancer Epidemiol. 2009, 33: 24-30. 10.1016/j.canep.2009.04.009.CrossRefPubMedPubMedCentral Kato I, Cichon M, Yee CL, Land S, Korczak JF: African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer. Cancer Epidemiol. 2009, 33: 24-30. 10.1016/j.canep.2009.04.009.CrossRefPubMedPubMedCentral
10.
go back to reference Taioli E, Trachman J, Chen X, Toniolo P, Garte SJ: A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res. 1995, 55: 3757-3758.PubMed Taioli E, Trachman J, Chen X, Toniolo P, Garte SJ: A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res. 1995, 55: 3757-3758.PubMed
11.
go back to reference Ray M, Polite BN: Triple-negative breast cancers: a view from 10,000 feet. Cancer J. 2010, 16: 17-22. 10.1097/PPO.0b013e3181d3eef5.CrossRefPubMed Ray M, Polite BN: Triple-negative breast cancers: a view from 10,000 feet. Cancer J. 2010, 16: 17-22. 10.1097/PPO.0b013e3181d3eef5.CrossRefPubMed
12.
go back to reference Joslyn SA: Hormone receptors in breast cancer: racial differences in distribution and survival. Breast Cancer Res Treat. 2002, 73: 45-59. 10.1023/A:1015220420400.CrossRefPubMed Joslyn SA: Hormone receptors in breast cancer: racial differences in distribution and survival. Breast Cancer Res Treat. 2002, 73: 45-59. 10.1023/A:1015220420400.CrossRefPubMed
13.
go back to reference Elledge RM, Clark GM, Chamness GC, Osborne CK: Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994, 86: 705-712. 10.1093/jnci/86.9.705.CrossRefPubMed Elledge RM, Clark GM, Chamness GC, Osborne CK: Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994, 86: 705-712. 10.1093/jnci/86.9.705.CrossRefPubMed
14.
go back to reference Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE: Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Am J Epidemiol. 2009, 169: 1251-1259. 10.1093/aje/kwp036.CrossRefPubMedPubMedCentral Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE: Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Am J Epidemiol. 2009, 169: 1251-1259. 10.1093/aje/kwp036.CrossRefPubMedPubMedCentral
15.
go back to reference Dunnwald LK, Rossing MA, Li CI: Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 2007, 9: R6-10.1186/bcr1639.CrossRefPubMedPubMedCentral Dunnwald LK, Rossing MA, Li CI: Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 2007, 9: R6-10.1186/bcr1639.CrossRefPubMedPubMedCentral
16.
go back to reference Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW: Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer. 2001, 92: 37-45. 10.1002/1097-0142(20010701)92:1<37::AID-CNCR1289>3.0.CO;2-F.CrossRefPubMed Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW: Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer. 2001, 92: 37-45. 10.1002/1097-0142(20010701)92:1<37::AID-CNCR1289>3.0.CO;2-F.CrossRefPubMed
17.
go back to reference Porter PL, Lund MJ, Lin MG, Yuan X, Liff JM, Flagg EW, Coates RJ, Eley JW: Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma. Cancer. 2004, 100: 2533-2542. 10.1002/cncr.20279.CrossRefPubMed Porter PL, Lund MJ, Lin MG, Yuan X, Liff JM, Flagg EW, Coates RJ, Eley JW: Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma. Cancer. 2004, 100: 2533-2542. 10.1002/cncr.20279.CrossRefPubMed
18.
go back to reference Martin DN, Boersma BJ, Yi M, Reimers M, Howe TM, Yfantis HG, Tsai YC, Williams EH, Lee DH, Stephens RM, Weissman AM, Ambs S: Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS ONE. 2009, 4: e4531-10.1371/journal.pone.0004531.CrossRefPubMedPubMedCentral Martin DN, Boersma BJ, Yi M, Reimers M, Howe TM, Yfantis HG, Tsai YC, Williams EH, Lee DH, Stephens RM, Weissman AM, Ambs S: Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS ONE. 2009, 4: e4531-10.1371/journal.pone.0004531.CrossRefPubMedPubMedCentral
19.
go back to reference Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SG, Eley JW: Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat. 2009, 113: 357-370. 10.1007/s10549-008-9926-3.CrossRefPubMed Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SG, Eley JW: Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat. 2009, 113: 357-370. 10.1007/s10549-008-9926-3.CrossRefPubMed
20.
go back to reference Gukas ID, Girling AC, Mandong BM, Prime W, Jennings BA, Leinster SJ: A comparison of clinicopathological features and molecular markers in british and nigerian women with breast cancer. Clin Med Oncol. 2008, 2: 347-351.PubMedPubMedCentral Gukas ID, Girling AC, Mandong BM, Prime W, Jennings BA, Leinster SJ: A comparison of clinicopathological features and molecular markers in british and nigerian women with breast cancer. Clin Med Oncol. 2008, 2: 347-351.PubMedPubMedCentral
21.
go back to reference Mehrotra J, Ganpat MM, Kanaan Y, Fackler MJ, McVeigh M, Lahti-Domenici J, Polyak K, Argani P, Naab T, Garrett E, Parmigiani G, Broome C, Sukumar S: Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women. Clin Cancer Res. 2004, 10: 2052-2057. 10.1158/1078-0432.CCR-03-0514.CrossRefPubMed Mehrotra J, Ganpat MM, Kanaan Y, Fackler MJ, McVeigh M, Lahti-Domenici J, Polyak K, Argani P, Naab T, Garrett E, Parmigiani G, Broome C, Sukumar S: Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women. Clin Cancer Res. 2004, 10: 2052-2057. 10.1158/1078-0432.CCR-03-0514.CrossRefPubMed
22.
go back to reference Dookeran KA, Dignam JJ, Ferrer K, Sekosan M, McCaskill-Stevens W, Gehlert S: p53 as a marker of prognosis in African-American women with breast cancer. Ann Surg Oncol. 2010, 17: 1398-1405. 10.1245/s10434-009-0889-3.CrossRefPubMed Dookeran KA, Dignam JJ, Ferrer K, Sekosan M, McCaskill-Stevens W, Gehlert S: p53 as a marker of prognosis in African-American women with breast cancer. Ann Surg Oncol. 2010, 17: 1398-1405. 10.1245/s10434-009-0889-3.CrossRefPubMed
23.
go back to reference Loo LW, Wang Y, Flynn EM, Lund MJ, Bowles EJ, Buist DS, Liff JM, Flagg EW, Coates RJ, Eley JW, Hsu L, Porter PL: Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women. Breast Cancer Res Treat. 2011, 127: 297-308. 10.1007/s10549-010-1297-x.CrossRefPubMedPubMedCentral Loo LW, Wang Y, Flynn EM, Lund MJ, Bowles EJ, Buist DS, Liff JM, Flagg EW, Coates RJ, Eley JW, Hsu L, Porter PL: Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women. Breast Cancer Res Treat. 2011, 127: 297-308. 10.1007/s10549-010-1297-x.CrossRefPubMedPubMedCentral
24.
go back to reference Jiang Y, Cui L, Chen WD, Shen SH, Ding LD: The prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published data. PLoS ONE. 2012, 7: e36780-10.1371/journal.pone.0036780.CrossRefPubMedPubMedCentral Jiang Y, Cui L, Chen WD, Shen SH, Ding LD: The prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published data. PLoS ONE. 2012, 7: e36780-10.1371/journal.pone.0036780.CrossRefPubMedPubMedCentral
25.
go back to reference Boyer-Chammard A, Taylor TH, Anton-Culver H: Survival differences in breast cancer among racial/ethnic groups: a population-based study. Cancer Detect Prev. 1999, 23: 463-473. 10.1046/j.1525-1500.1999.99049.x.CrossRefPubMed Boyer-Chammard A, Taylor TH, Anton-Culver H: Survival differences in breast cancer among racial/ethnic groups: a population-based study. Cancer Detect Prev. 1999, 23: 463-473. 10.1046/j.1525-1500.1999.99049.x.CrossRefPubMed
26.
go back to reference Joslyn SA, West MM: Racial differences in breast carcinoma survival. Cancer. 2000, 88: 114-123. 10.1002/(SICI)1097-0142(20000101)88:1<114::AID-CNCR16>3.0.CO;2-J.CrossRefPubMed Joslyn SA, West MM: Racial differences in breast carcinoma survival. Cancer. 2000, 88: 114-123. 10.1002/(SICI)1097-0142(20000101)88:1<114::AID-CNCR16>3.0.CO;2-J.CrossRefPubMed
27.
go back to reference Adams SA, Butler WM, Fulton J, Heiney SP, Williams EM, Delage AF, Khang L, Hebert JR: Racial disparities in breast cancer mortality in a multiethnic cohort in the Southeast. Cancer. 2011, 118: 2693-2699.CrossRefPubMedPubMedCentral Adams SA, Butler WM, Fulton J, Heiney SP, Williams EM, Delage AF, Khang L, Hebert JR: Racial disparities in breast cancer mortality in a multiethnic cohort in the Southeast. Cancer. 2011, 118: 2693-2699.CrossRefPubMedPubMedCentral
28.
go back to reference Zaloznik AJ: Breast cancer stage at diagnosis: Caucasians versus Afro-Americans. Breast Cancer Res Treat. 1995, 34: 195-198. 10.1007/BF00689710.CrossRefPubMed Zaloznik AJ: Breast cancer stage at diagnosis: Caucasians versus Afro-Americans. Breast Cancer Res Treat. 1995, 34: 195-198. 10.1007/BF00689710.CrossRefPubMed
29.
go back to reference Althuis MD, Brogan DD, Coates RJ, Daling JR, Gammon MD, Malone KE, Schoenberg JB, Brinton LA: Breast cancers among very young premenopausal women (United States). Cancer Causes Control. 2003, 14: 151-160. 10.1023/A:1023006000760.CrossRefPubMed Althuis MD, Brogan DD, Coates RJ, Daling JR, Gammon MD, Malone KE, Schoenberg JB, Brinton LA: Breast cancers among very young premenopausal women (United States). Cancer Causes Control. 2003, 14: 151-160. 10.1023/A:1023006000760.CrossRefPubMed
30.
go back to reference Johnson ET: Breast cancer racial differences before age 40 - implications for screening. J Natl Med Assoc. 2002, 94: 149-156.PubMedPubMedCentral Johnson ET: Breast cancer racial differences before age 40 - implications for screening. J Natl Med Assoc. 2002, 94: 149-156.PubMedPubMedCentral
31.
go back to reference Kurian AW, Fish K, Shema SJ, Clarke CA: Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res. 2010, 12: R99-10.1186/bcr2780.CrossRefPubMedPubMedCentral Kurian AW, Fish K, Shema SJ, Clarke CA: Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res. 2010, 12: R99-10.1186/bcr2780.CrossRefPubMedPubMedCentral
32.
go back to reference Aziz H, Hussain F, Sohn C, Mediavillo R, Saitta A, Hussain A, Brandys M, Homel P, Rotman M: Early onset of breast carcinoma in African American women with poor prognostic factors. Am J Clin Oncol. 1999, 22: 436-440. 10.1097/00000421-199910000-00002.CrossRefPubMed Aziz H, Hussain F, Sohn C, Mediavillo R, Saitta A, Hussain A, Brandys M, Homel P, Rotman M: Early onset of breast carcinoma in African American women with poor prognostic factors. Am J Clin Oncol. 1999, 22: 436-440. 10.1097/00000421-199910000-00002.CrossRefPubMed
33.
go back to reference Demicheli R, Retsky MW, Hrushesky WJ, Baum M, Gukas ID, Jatoi I: Racial disparities in breast cancer outcome: insights into host-tumor interactions. Cancer. 2007, 110: 1880-1888. 10.1002/cncr.22998.CrossRefPubMed Demicheli R, Retsky MW, Hrushesky WJ, Baum M, Gukas ID, Jatoi I: Racial disparities in breast cancer outcome: insights into host-tumor interactions. Cancer. 2007, 110: 1880-1888. 10.1002/cncr.22998.CrossRefPubMed
34.
go back to reference Ruiz-Narvaez EA, Rosenberg L, Cozier YC, Cupples LA, Adams-Campbell LL, Palmer JR: Polymorphisms in the TOX3/LOC643714 locus and risk of breast cancer in African-American women. Cancer Epidemiol Biomarkers Prev. 2010, 19: 1320-1327. 10.1158/1055-9965.EPI-09-1250.CrossRefPubMedPubMedCentral Ruiz-Narvaez EA, Rosenberg L, Cozier YC, Cupples LA, Adams-Campbell LL, Palmer JR: Polymorphisms in the TOX3/LOC643714 locus and risk of breast cancer in African-American women. Cancer Epidemiol Biomarkers Prev. 2010, 19: 1320-1327. 10.1158/1055-9965.EPI-09-1250.CrossRefPubMedPubMedCentral
35.
go back to reference Yager JD, Davidson NE: Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006, 354: 270-282. 10.1056/NEJMra050776.CrossRefPubMed Yager JD, Davidson NE: Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006, 354: 270-282. 10.1056/NEJMra050776.CrossRefPubMed
36.
go back to reference Perou CM: Molecular stratification of triple-negative breast cancers. Oncologist. 2011, 16 (Suppl 1): 61-70.CrossRefPubMed Perou CM: Molecular stratification of triple-negative breast cancers. Oncologist. 2011, 16 (Suppl 1): 61-70.CrossRefPubMed
37.
go back to reference Loden M, Stighall M, Nielsen NH, Roos G, Emdin SO, Ostlund H, Landberg G: The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node. Oncogene. 2002, 21: 4680-4690. 10.1038/sj.onc.1205578.CrossRefPubMed Loden M, Stighall M, Nielsen NH, Roos G, Emdin SO, Ostlund H, Landberg G: The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node. Oncogene. 2002, 21: 4680-4690. 10.1038/sj.onc.1205578.CrossRefPubMed
38.
go back to reference Nielsen NH, Arnerlov C, Emdin SO, Landberg G: Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br J Cancer. 1996, 74: 874-880. 10.1038/bjc.1996.451.CrossRefPubMedPubMedCentral Nielsen NH, Arnerlov C, Emdin SO, Landberg G: Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br J Cancer. 1996, 74: 874-880. 10.1038/bjc.1996.451.CrossRefPubMedPubMedCentral
39.
go back to reference Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y, McCue P, Schwartz GF, Park PK, Rosenberg AL, Brill K, Mitchell EP: Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Cancer. 2007, 110: 876-884. 10.1002/cncr.22836.CrossRefPubMed Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y, McCue P, Schwartz GF, Park PK, Rosenberg AL, Brill K, Mitchell EP: Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Cancer. 2007, 110: 876-884. 10.1002/cncr.22836.CrossRefPubMed
40.
go back to reference Caleffi M, Teague MW, Jensen RA, Vnencak-Jones CL, Dupont WD, Parl FF: p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment. Cancer. 1994, 73: 2147-2156. 10.1002/1097-0142(19940415)73:8<2147::AID-CNCR2820730820>3.0.CO;2-5.CrossRefPubMed Caleffi M, Teague MW, Jensen RA, Vnencak-Jones CL, Dupont WD, Parl FF: p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment. Cancer. 1994, 73: 2147-2156. 10.1002/1097-0142(19940415)73:8<2147::AID-CNCR2820730820>3.0.CO;2-5.CrossRefPubMed
41.
go back to reference Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK, McGuire WL: Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst. 1993, 85: 200-206. 10.1093/jnci/85.3.200.CrossRefPubMed Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK, McGuire WL: Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst. 1993, 85: 200-206. 10.1093/jnci/85.3.200.CrossRefPubMed
42.
go back to reference Donninger H, Vos MD, Clark GJ: The RASSF1A tumor suppressor. J Cell Sci. 2007, 120: 3163-3172. 10.1242/jcs.010389.CrossRefPubMed Donninger H, Vos MD, Clark GJ: The RASSF1A tumor suppressor. J Cell Sci. 2007, 120: 3163-3172. 10.1242/jcs.010389.CrossRefPubMed
43.
go back to reference Krop I, Parker MT, Bloushtain-Qimron N, Porter D, Gelman R, Sasaki H, Maurer M, Terry MB, Parsons R, Polyak K: HIN-1, an inhibitor of cell growth, invasion, and AKT activation. Cancer Res. 2005, 65: 9659-9669. 10.1158/0008-5472.CAN-05-1663.CrossRefPubMed Krop I, Parker MT, Bloushtain-Qimron N, Porter D, Gelman R, Sasaki H, Maurer M, Terry MB, Parsons R, Polyak K: HIN-1, an inhibitor of cell growth, invasion, and AKT activation. Cancer Res. 2005, 65: 9659-9669. 10.1158/0008-5472.CAN-05-1663.CrossRefPubMed
44.
go back to reference Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL: Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008, 26: 3324-3330. 10.1200/JCO.2007.14.2471.CrossRefPubMed Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL: Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008, 26: 3324-3330. 10.1200/JCO.2007.14.2471.CrossRefPubMed
45.
go back to reference Azim HA, Michiels S, Bedard PL, Singhal SK, Criscitiello C, Ignatiadis M, Haibe-Kains B, Piccart MJ, Sotiriou C, Loi S: Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling. Clin Cancer Res. 2012, 18: 1341-1351. 10.1158/1078-0432.CCR-11-2599.CrossRefPubMed Azim HA, Michiels S, Bedard PL, Singhal SK, Criscitiello C, Ignatiadis M, Haibe-Kains B, Piccart MJ, Sotiriou C, Loi S: Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling. Clin Cancer Res. 2012, 18: 1341-1351. 10.1158/1078-0432.CCR-11-2599.CrossRefPubMed
46.
go back to reference Ihemelandu CU, Leffall LD, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA: Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome. Ann Surg Oncol. 2007, 14: 2994-3003. 10.1245/s10434-007-9477-6.CrossRefPubMed Ihemelandu CU, Leffall LD, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA: Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome. Ann Surg Oncol. 2007, 14: 2994-3003. 10.1245/s10434-007-9477-6.CrossRefPubMed
47.
go back to reference Albain S, Barlow WE, Shak S, Hortobagyi GN, Hayes DF: Potential biologic causes of the racial survival disparity in adjuvant trials of ER-positive breast cancer. J Clin Oncol. 2010, 28 (Suppl): 511- Albain S, Barlow WE, Shak S, Hortobagyi GN, Hayes DF: Potential biologic causes of the racial survival disparity in adjuvant trials of ER-positive breast cancer. J Clin Oncol. 2010, 28 (Suppl): 511-
48.
go back to reference Bruzzi P, Negri E, La VC, Decarli A, Palli D, Parazzini F, Del Turco MR: Short term increase in risk of breast cancer after full term pregnancy. BMJ. 1988, 297: 1096-1098. 10.1136/bmj.297.6656.1096.CrossRefPubMedPubMedCentral Bruzzi P, Negri E, La VC, Decarli A, Palli D, Parazzini F, Del Turco MR: Short term increase in risk of breast cancer after full term pregnancy. BMJ. 1988, 297: 1096-1098. 10.1136/bmj.297.6656.1096.CrossRefPubMedPubMedCentral
49.
go back to reference Pathak DR, Osuch JR, He J: Breast carcinoma etiology: current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations. Cancer. 2000, 88: 1230-1238. 10.1002/(SICI)1097-0142(20000301)88:5+<1230::AID-CNCR9>3.0.CO;2-F.CrossRefPubMed Pathak DR, Osuch JR, He J: Breast carcinoma etiology: current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations. Cancer. 2000, 88: 1230-1238. 10.1002/(SICI)1097-0142(20000301)88:5+<1230::AID-CNCR9>3.0.CO;2-F.CrossRefPubMed
50.
go back to reference Mukhina S, Mertani HC, Guo K, Lee KO, Gluckman PD, Lobie PE: Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone. Proc Natl Acad Sci USA. 2004, 101: 15166-15171. 10.1073/pnas.0405881101.CrossRefPubMedPubMedCentral Mukhina S, Mertani HC, Guo K, Lee KO, Gluckman PD, Lobie PE: Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone. Proc Natl Acad Sci USA. 2004, 101: 15166-15171. 10.1073/pnas.0405881101.CrossRefPubMedPubMedCentral
51.
go back to reference Key TJ, Appleby PN, Reeves GK, Roddam AW: Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol. 2010, 11: 530-542.CrossRefPubMed Key TJ, Appleby PN, Reeves GK, Roddam AW: Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol. 2010, 11: 530-542.CrossRefPubMed
52.
go back to reference Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM: Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. 2008, 109: 123-139. 10.1007/s10549-007-9632-6.CrossRefPubMed Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM: Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. 2008, 109: 123-139. 10.1007/s10549-007-9632-6.CrossRefPubMed
53.
go back to reference Li R, Fridinger F, Grummer-Strawn L: Racial/ethnic disparities in public opinion about breastfeeding: the 1999-2000 healthstyles surveys in the United States. Adv Exp Med Biol. 2004, 554: 287-291. 10.1007/978-1-4757-4242-8_24.CrossRefPubMed Li R, Fridinger F, Grummer-Strawn L: Racial/ethnic disparities in public opinion about breastfeeding: the 1999-2000 healthstyles surveys in the United States. Adv Exp Med Biol. 2004, 554: 287-291. 10.1007/978-1-4757-4242-8_24.CrossRefPubMed
54.
go back to reference Baquet CR, Mishra SI, Commiskey P, Ellison GL, DeShields M: Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc. 2008, 100: 480-488.CrossRefPubMedPubMedCentral Baquet CR, Mishra SI, Commiskey P, Ellison GL, DeShields M: Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc. 2008, 100: 480-488.CrossRefPubMedPubMedCentral
55.
go back to reference Hunter CP: Epidemiology, stage at diagnosis, and tumor biology of breast carcinoma in multiracial and multiethnic populations. Cancer. 2000, 88: 1193-1202. 10.1002/(SICI)1097-0142(20000301)88:5+<1193::AID-CNCR3>3.0.CO;2-D.CrossRefPubMed Hunter CP: Epidemiology, stage at diagnosis, and tumor biology of breast carcinoma in multiracial and multiethnic populations. Cancer. 2000, 88: 1193-1202. 10.1002/(SICI)1097-0142(20000301)88:5+<1193::AID-CNCR3>3.0.CO;2-D.CrossRefPubMed
56.
go back to reference Lantz PM, Mujahid M, Schwartz K, Janz NK, Fagerlin A, Salem B, Liu L, Deapen D, Katz SJ: The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health. 2006, 96: 2173-2178. 10.2105/AJPH.2005.072132.CrossRefPubMedPubMedCentral Lantz PM, Mujahid M, Schwartz K, Janz NK, Fagerlin A, Salem B, Liu L, Deapen D, Katz SJ: The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health. 2006, 96: 2173-2178. 10.2105/AJPH.2005.072132.CrossRefPubMedPubMedCentral
57.
go back to reference Chu KC, Lamar CA, Freeman HP: Racial disparities in breast carcinoma survival rates: seperating factors that affect diagnosis from factors that affect treatment. Cancer. 2003, 97: 2853-2860. 10.1002/cncr.11411.CrossRefPubMed Chu KC, Lamar CA, Freeman HP: Racial disparities in breast carcinoma survival rates: seperating factors that affect diagnosis from factors that affect treatment. Cancer. 2003, 97: 2853-2860. 10.1002/cncr.11411.CrossRefPubMed
58.
go back to reference Reihani S, Akushevich I, Schildkraut J, Il'yasova D: Inflammatory breast cancer rates among different ethnic and rcial groups in the United States. Cancer Res. 2011, 71 (Suppl 1): 3732-CrossRef Reihani S, Akushevich I, Schildkraut J, Il'yasova D: Inflammatory breast cancer rates among different ethnic and rcial groups in the United States. Cancer Res. 2011, 71 (Suppl 1): 3732-CrossRef
59.
go back to reference Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V: Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. 2007, 109: 1721-1728. 10.1002/cncr.22618.CrossRefPubMed Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V: Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. 2007, 109: 1721-1728. 10.1002/cncr.22618.CrossRefPubMed
60.
go back to reference Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA: Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007, 13: 4429-4434. 10.1158/1078-0432.CCR-06-3045.CrossRefPubMed Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA: Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007, 13: 4429-4434. 10.1158/1078-0432.CCR-06-3045.CrossRefPubMed
61.
go back to reference Dunnwald LK, Rossing MA, Li CI: Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 2007, 9: R6-10.1186/bcr1639.CrossRefPubMedPubMedCentral Dunnwald LK, Rossing MA, Li CI: Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 2007, 9: R6-10.1186/bcr1639.CrossRefPubMedPubMedCentral
62.
go back to reference Hunter CP, Redmond CK, Chen VW, Austin DF, Greenberg RS, Correa P, Muss HB, Forman MR, Wesley MN, Blacklow RS: Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst. 1993, 85: 1129-1137. 10.1093/jnci/85.14.1129.CrossRefPubMed Hunter CP, Redmond CK, Chen VW, Austin DF, Greenberg RS, Correa P, Muss HB, Forman MR, Wesley MN, Blacklow RS: Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst. 1993, 85: 1129-1137. 10.1093/jnci/85.14.1129.CrossRefPubMed
63.
go back to reference Shinozaki M, Hoon DS, Giuliano AE, Hansen NM, Wang HJ, Turner R, Taback B: Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis. Clin Cancer Res. 2005, 11: 2156-2162. 10.1158/1078-0432.CCR-04-1810.CrossRefPubMed Shinozaki M, Hoon DS, Giuliano AE, Hansen NM, Wang HJ, Turner R, Taback B: Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis. Clin Cancer Res. 2005, 11: 2156-2162. 10.1158/1078-0432.CCR-04-1810.CrossRefPubMed
64.
go back to reference Hoffman HJ, LaVerda NL, Levine PH, Young HA, Alexander LM, Patierno SR: Having health insurance does not eliminate race/ethnicity-associated delays in breast cancer diagnosis in the District of Columbia. Cancer. 2011, 117: 3824-3832. 10.1002/cncr.25970.CrossRefPubMedPubMedCentral Hoffman HJ, LaVerda NL, Levine PH, Young HA, Alexander LM, Patierno SR: Having health insurance does not eliminate race/ethnicity-associated delays in breast cancer diagnosis in the District of Columbia. Cancer. 2011, 117: 3824-3832. 10.1002/cncr.25970.CrossRefPubMedPubMedCentral
65.
go back to reference Sheinfeld SN, Gorin J, Heck E, Gorin JE: Delay in breast cancer diagnosis by race/ethnicity. J Clin Oncol. 2005, 23 (Suppl): 16S- Sheinfeld SN, Gorin J, Heck E, Gorin JE: Delay in breast cancer diagnosis by race/ethnicity. J Clin Oncol. 2005, 23 (Suppl): 16S-
66.
go back to reference Lannin DR, Mathews HF, Mitchell J, Swanson MS, Swanson FH, Edwards MS: Influence of socioeconomic and cultural factors on racial differences in latestage presentation of breast cancer. JAMA. 1998, 279: 1801-1807. 10.1001/jama.279.22.1801.CrossRefPubMed Lannin DR, Mathews HF, Mitchell J, Swanson MS, Swanson FH, Edwards MS: Influence of socioeconomic and cultural factors on racial differences in latestage presentation of breast cancer. JAMA. 1998, 279: 1801-1807. 10.1001/jama.279.22.1801.CrossRefPubMed
67.
go back to reference Trock BJ: Breast cancer in African American women: epidemiology and tumor biology. Breast Cancer Res Treat. 1996, 40: 11-24. 10.1007/BF01805999.CrossRefPubMed Trock BJ: Breast cancer in African American women: epidemiology and tumor biology. Breast Cancer Res Treat. 1996, 40: 11-24. 10.1007/BF01805999.CrossRefPubMed
68.
go back to reference Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA: Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007, 13: 4429-4434. 10.1158/1078-0432.CCR-06-3045.CrossRefPubMed Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA: Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007, 13: 4429-4434. 10.1158/1078-0432.CCR-06-3045.CrossRefPubMed
69.
go back to reference Collett K, Stefansson IM, Eide J, Braaten A, Wang H, Eide GE, Thoresen SO, Foulkes WD, Akslen LA: A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1108-1112. 10.1158/1055-9965.EPI-04-0394.CrossRefPubMed Collett K, Stefansson IM, Eide J, Braaten A, Wang H, Eide GE, Thoresen SO, Foulkes WD, Akslen LA: A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1108-1112. 10.1158/1055-9965.EPI-04-0394.CrossRefPubMed
70.
go back to reference Bandera EV, Chandran U, Zirpoli G, Ciupak G, Hwang H, McCann S, Pawlish K, Jandorf L, Bovbjerg D, Ambrosone C: Anthropometric factors and breast cancer among African American women participating in the Women's Circle of Health Study. Cancer Res. 2012, 72: 649-10.1158/1538-7445.AM2012-649.CrossRef Bandera EV, Chandran U, Zirpoli G, Ciupak G, Hwang H, McCann S, Pawlish K, Jandorf L, Bovbjerg D, Ambrosone C: Anthropometric factors and breast cancer among African American women participating in the Women's Circle of Health Study. Cancer Res. 2012, 72: 649-10.1158/1538-7445.AM2012-649.CrossRef
71.
go back to reference Ownby HE, Frederick J, Russo J, Brooks SC, Swanson GM, Heppner GH, Brennan MJ: Racial differences in breast cancer patients. J Natl Cancer Inst. 1985, 75: 55-60.PubMed Ownby HE, Frederick J, Russo J, Brooks SC, Swanson GM, Heppner GH, Brennan MJ: Racial differences in breast cancer patients. J Natl Cancer Inst. 1985, 75: 55-60.PubMed
72.
go back to reference Elmore JG, Moceri VM, Carter D, Larson EB: Breast carcinoma tumor characteristics in black and white women. Cancer. 1998, 83: 2509-2515. 10.1002/(SICI)1097-0142(19981215)83:12<2509::AID-CNCR15>3.0.CO;2-V.CrossRefPubMed Elmore JG, Moceri VM, Carter D, Larson EB: Breast carcinoma tumor characteristics in black and white women. Cancer. 1998, 83: 2509-2515. 10.1002/(SICI)1097-0142(19981215)83:12<2509::AID-CNCR15>3.0.CO;2-V.CrossRefPubMed
73.
go back to reference Furberg H, Millikan R, Dressler L, Newman B, Geradts J: Tumor characteristics in African American and white women. Breast Cancer Res Treat. 2001, 68: 33-43. 10.1023/A:1017994726207.CrossRefPubMed Furberg H, Millikan R, Dressler L, Newman B, Geradts J: Tumor characteristics in African American and white women. Breast Cancer Res Treat. 2001, 68: 33-43. 10.1023/A:1017994726207.CrossRefPubMed
74.
go back to reference Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC: Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006, 295: 2492-2502. 10.1001/jama.295.21.2492.CrossRefPubMed Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC: Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006, 295: 2492-2502. 10.1001/jama.295.21.2492.CrossRefPubMed
75.
go back to reference Landberg G: Multiparameter analyses of cell cycle regulatory proteins in human breast cancer: a key to definition of separate pathways in tumorigenesis. Adv Cancer Res. 2002, 84: 35-56.CrossRefPubMed Landberg G: Multiparameter analyses of cell cycle regulatory proteins in human breast cancer: a key to definition of separate pathways in tumorigenesis. Adv Cancer Res. 2002, 84: 35-56.CrossRefPubMed
76.
go back to reference Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, Herliczek TW, Bacus SS: Cyclin E and survival in patients with breast cancer. N Engl J Med. 2002, 347: 1566-1575. 10.1056/NEJMoa021153.CrossRefPubMed Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, Herliczek TW, Bacus SS: Cyclin E and survival in patients with breast cancer. N Engl J Med. 2002, 347: 1566-1575. 10.1056/NEJMoa021153.CrossRefPubMed
77.
go back to reference Rodriguez-Gil J, Hill J, Allen G, Thomas V, Hu J: Racial/ethnic differences in double-strand break repair signaling in breast cancer. Cancer Res. 2010, 70: 4704-10.1158/1538-7445.AM10-4704.CrossRef Rodriguez-Gil J, Hill J, Allen G, Thomas V, Hu J: Racial/ethnic differences in double-strand break repair signaling in breast cancer. Cancer Res. 2010, 70: 4704-10.1158/1538-7445.AM10-4704.CrossRef
78.
go back to reference Dowle CS, Owainati A, Robins A, Burns K, Ellis IO, Elston CW, Blamey RW: Prognostic significance of the DNA content of human breast cancer. Br J Surg. 1987, 74: 133-136. 10.1002/bjs.1800740221.CrossRefPubMed Dowle CS, Owainati A, Robins A, Burns K, Ellis IO, Elston CW, Blamey RW: Prognostic significance of the DNA content of human breast cancer. Br J Surg. 1987, 74: 133-136. 10.1002/bjs.1800740221.CrossRefPubMed
79.
go back to reference Kallioniemi OP, Hietanen T, Mattila J, Lehtinen M, Lauslahti K, Koivula T: Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer. Eur J Cancer Clin Oncol. 1987, 23: 277-282. 10.1016/0277-5379(87)90071-X.CrossRefPubMed Kallioniemi OP, Hietanen T, Mattila J, Lehtinen M, Lauslahti K, Koivula T: Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer. Eur J Cancer Clin Oncol. 1987, 23: 277-282. 10.1016/0277-5379(87)90071-X.CrossRefPubMed
80.
go back to reference Tarapore P, Fukasawa K: Loss of p53 and centrosome hyperamplification. Oncogene. 2002, 21: 6234-6240. 10.1038/sj.onc.1205707.CrossRefPubMed Tarapore P, Fukasawa K: Loss of p53 and centrosome hyperamplification. Oncogene. 2002, 21: 6234-6240. 10.1038/sj.onc.1205707.CrossRefPubMed
81.
go back to reference Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de RM, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein LP, Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001, 98: 10869-10874. 10.1073/pnas.191367098.CrossRefPubMedPubMedCentral Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de RM, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein LP, Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001, 98: 10869-10874. 10.1073/pnas.191367098.CrossRefPubMedPubMedCentral
82.
go back to reference Tammemagi CM: Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes. Curr Opin Obstet Gynecol. 2007, 19: 31-36. 10.1097/GCO.0b013e3280117cf8.CrossRefPubMed Tammemagi CM: Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes. Curr Opin Obstet Gynecol. 2007, 19: 31-36. 10.1097/GCO.0b013e3280117cf8.CrossRefPubMed
83.
go back to reference Schairer C, Mink PJ, Carroll L, Devesa SS: Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst. 2004, 96: 1311-1321. 10.1093/jnci/djh253.CrossRefPubMed Schairer C, Mink PJ, Carroll L, Devesa SS: Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst. 2004, 96: 1311-1321. 10.1093/jnci/djh253.CrossRefPubMed
84.
go back to reference Field TS, Buist DS, Doubeni C, Enger S, Fouayzi H, Hart G, Korner EJ, Lamerato L, Bachman DJ, Ellis J, Herrinton L, Hornbrook MC, Krajenta R, Liu L, Yao J: Disparities and survival among breast cancer patients. J Natl Cancer Inst Monogr. 2005, 35: 88-95.CrossRef Field TS, Buist DS, Doubeni C, Enger S, Fouayzi H, Hart G, Korner EJ, Lamerato L, Bachman DJ, Ellis J, Herrinton L, Hornbrook MC, Krajenta R, Liu L, Yao J: Disparities and survival among breast cancer patients. J Natl Cancer Inst Monogr. 2005, 35: 88-95.CrossRef
85.
go back to reference Henson DE, Chu KC, Levine PH: Histologic grade, stage, and survival in breast carcinoma: comparison of African American and Caucasian women. Cancer. 2003, 98: 908-917. 10.1002/cncr.11558.CrossRefPubMed Henson DE, Chu KC, Levine PH: Histologic grade, stage, and survival in breast carcinoma: comparison of African American and Caucasian women. Cancer. 2003, 98: 908-917. 10.1002/cncr.11558.CrossRefPubMed
86.
go back to reference Hirschman J, Whitman S, Ansell D: The black:white disparity in breast cancer mortality: the example of Chicago. Cancer Causes Control. 2007, 18: 323-333. 10.1007/s10552-006-0102-y.CrossRefPubMed Hirschman J, Whitman S, Ansell D: The black:white disparity in breast cancer mortality: the example of Chicago. Cancer Causes Control. 2007, 18: 323-333. 10.1007/s10552-006-0102-y.CrossRefPubMed
87.
go back to reference Lu Y, Ma H, Malone KE, Norman SA, Sullivan-Halley J, Strom BL, Marchbanks PA, Spirtas R, Burkman RT, Deapen D, Folger SG, Simon MS, Press MF, McDonald JA, Bernstein L: Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer. J Clin Oncol. 2011, 29: 3358-3365. 10.1200/JCO.2010.34.2048.CrossRefPubMedPubMedCentral Lu Y, Ma H, Malone KE, Norman SA, Sullivan-Halley J, Strom BL, Marchbanks PA, Spirtas R, Burkman RT, Deapen D, Folger SG, Simon MS, Press MF, McDonald JA, Bernstein L: Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer. J Clin Oncol. 2011, 29: 3358-3365. 10.1200/JCO.2010.34.2048.CrossRefPubMedPubMedCentral
88.
go back to reference Gillett C, Smith P, Gregory W, Richards M, Millis R, Peters G, Barnes D: Cyclin D1 and prognosis in human breast cancer. Int J Cancer. 1996, 69: 92-99. 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.0.CO;2-Q.CrossRefPubMed Gillett C, Smith P, Gregory W, Richards M, Millis R, Peters G, Barnes D: Cyclin D1 and prognosis in human breast cancer. Int J Cancer. 1996, 69: 92-99. 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.0.CO;2-Q.CrossRefPubMed
89.
go back to reference Donnellan R, Kleinschmidt I, Chetty R: Cyclin E immunoexpression in breast ductal carcinoma: pathologic correlations and prognostic implications. Hum Pathol. 2001, 32: 89-94. 10.1053/hupa.2001.21141.CrossRefPubMed Donnellan R, Kleinschmidt I, Chetty R: Cyclin E immunoexpression in breast ductal carcinoma: pathologic correlations and prognostic implications. Hum Pathol. 2001, 32: 89-94. 10.1053/hupa.2001.21141.CrossRefPubMed
90.
go back to reference Nielsen NH, Emdin SO, Cajander J, Landberg G: Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene. 1997, 14: 295-304. 10.1038/sj.onc.1200833.CrossRefPubMed Nielsen NH, Emdin SO, Cajander J, Landberg G: Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene. 1997, 14: 295-304. 10.1038/sj.onc.1200833.CrossRefPubMed
91.
go back to reference Li HP, Ji JF, Hou KY, Lei YT, Zhao HM, Wang J, Zheng J, Liu JY, Wang MP, Xiao Y, Wang YF, Lu YY, Sun Y: Prediction of recurrence risk in early breast cancer using human epidermal growth factor 2 and cyclin A2. Chin Med J (Engl). 2010, 123: 431-437. Li HP, Ji JF, Hou KY, Lei YT, Zhao HM, Wang J, Zheng J, Liu JY, Wang MP, Xiao Y, Wang YF, Lu YY, Sun Y: Prediction of recurrence risk in early breast cancer using human epidermal growth factor 2 and cyclin A2. Chin Med J (Engl). 2010, 123: 431-437.
92.
go back to reference Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, Alsner J, Stemke-Hale K, Lluch A, Neve RM, Kuo WL, Sorlie T, Sahin A, Valero V, Keyomarsi K, Gray JW, Borresen-Dale AL, Mills GB, Hennessy BT: Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer. Clin Cancer Res. 2009, 15: 3654-3662. 10.1158/1078-0432.CCR-08-3293.CrossRefPubMedPubMedCentral Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, Alsner J, Stemke-Hale K, Lluch A, Neve RM, Kuo WL, Sorlie T, Sahin A, Valero V, Keyomarsi K, Gray JW, Borresen-Dale AL, Mills GB, Hennessy BT: Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer. Clin Cancer Res. 2009, 15: 3654-3662. 10.1158/1078-0432.CCR-08-3293.CrossRefPubMedPubMedCentral
93.
go back to reference Aaltonen K, Amini RM, Heikkila P, Aittomaki K, Tamminen A, Nevanlinna H, Blomqvist C: High cyclin B1 expression is associated with poor survival in breast cancer. Br J Cancer. 2009, 100: 1055-1060. 10.1038/sj.bjc.6604874.CrossRefPubMedPubMedCentral Aaltonen K, Amini RM, Heikkila P, Aittomaki K, Tamminen A, Nevanlinna H, Blomqvist C: High cyclin B1 expression is associated with poor survival in breast cancer. Br J Cancer. 2009, 100: 1055-1060. 10.1038/sj.bjc.6604874.CrossRefPubMedPubMedCentral
94.
go back to reference Shiao YH, Chen VW, Scheer WD, Wu XC, Correa P: Racial disparity in the association of p53 gene alterations with breast cancer survival. Cancer Res. 1995, 55: 1485-1490.PubMed Shiao YH, Chen VW, Scheer WD, Wu XC, Correa P: Racial disparity in the association of p53 gene alterations with breast cancer survival. Cancer Res. 1995, 55: 1485-1490.PubMed
95.
go back to reference Blaszyk H, Vaughn CB, Hartmann A, McGovern RM, Schroeder JJ, Cunningham J, Schaid D, Sommer SS, Kovach JS: Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer. Lancet. 1994, 343: 1195-1197. 10.1016/S0140-6736(94)92403-1.CrossRefPubMed Blaszyk H, Vaughn CB, Hartmann A, McGovern RM, Schroeder JJ, Cunningham J, Schaid D, Sommer SS, Kovach JS: Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer. Lancet. 1994, 343: 1195-1197. 10.1016/S0140-6736(94)92403-1.CrossRefPubMed
96.
go back to reference Ihemelandu CU, Naab TJ, Mezghebe HM, Makambi KH, Siram SM, Leffall LD, DeWitty RL, Frederick WA: Treatment and survival outcome for molecular breast cancer subtypes in black women. Ann Surg. 2008, 247: 463-469. 10.1097/SLA.0b013e31815d744a.CrossRefPubMed Ihemelandu CU, Naab TJ, Mezghebe HM, Makambi KH, Siram SM, Leffall LD, DeWitty RL, Frederick WA: Treatment and survival outcome for molecular breast cancer subtypes in black women. Ann Surg. 2008, 247: 463-469. 10.1097/SLA.0b013e31815d744a.CrossRefPubMed
97.
go back to reference van Ravesteyn NT, Schechter CB, Near AM, Heijnsdijk EA, Stoto MA, Draisma G, de Koning HJ, Mandelblatt JS: Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States. Cancer Epidemiol Biomarkers Prev. 2011, 20: 112-122. 10.1158/1055-9965.EPI-10-0944.CrossRefPubMed van Ravesteyn NT, Schechter CB, Near AM, Heijnsdijk EA, Stoto MA, Draisma G, de Koning HJ, Mandelblatt JS: Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States. Cancer Epidemiol Biomarkers Prev. 2011, 20: 112-122. 10.1158/1055-9965.EPI-10-0944.CrossRefPubMed
98.
go back to reference Daling JR, Malone KE, Doody DR, Anderson BO, Porter PL: The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol Biomarkers Prev. 2002, 11: 235-241.PubMed Daling JR, Malone KE, Doody DR, Anderson BO, Porter PL: The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol Biomarkers Prev. 2002, 11: 235-241.PubMed
99.
go back to reference Wang Y, Zhou BP: Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin J Cancer. 2011, 30: 603-611. 10.5732/cjc.011.10226.CrossRefPubMedPubMedCentral Wang Y, Zhou BP: Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin J Cancer. 2011, 30: 603-611. 10.5732/cjc.011.10226.CrossRefPubMedPubMedCentral
100.
go back to reference Curtis E, Quale C, Haggstrom D, Smith-Bindman R: Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics?. Cancer. 2008, 112: 171-180. 10.1002/cncr.23131.CrossRefPubMedPubMedCentral Curtis E, Quale C, Haggstrom D, Smith-Bindman R: Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics?. Cancer. 2008, 112: 171-180. 10.1002/cncr.23131.CrossRefPubMedPubMedCentral
Metadata
Title
Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors
Author
David N Danforth Jr Jr
Publication date
01-06-2013
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 3/2013
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3429

Other articles of this Issue 3/2013

Breast Cancer Research 3/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine